• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:陈世贤,梁笑笑,时海燕,张霈,林晓晴,黄欣.LC-MS/MS法测定肿瘤患者血浆中帕米帕利浓度[J].药学研究,2024,43(5):439-443[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3040次   下载 2922次 本文二维码信息
码上扫一扫!
LC-MS/MS法测定肿瘤患者血浆中帕米帕利浓度
陈世贤1,梁笑笑1,时海燕2,张霈3,林晓晴2,黄欣1,2,3
字体:加大+|默认|缩小-
(1.山东中医药大学药学院,山东 济南 250355;2.山东第一医科大学第一附属医院<山东省千佛山医院>药学部,山东 济南 250014;3.山东第一医科大学药学院,山东 济南 250117)
摘要:
目的 建立液相色谱-质谱联用 (LC-MS/MS) 法测定肿瘤患者血浆中帕米帕利浓度的方法。方法 使用乙腈沉淀血浆蛋白,以呋塞米为内标,采用LC-MS/MS测定帕米帕利的血药浓度。采用GL Sciences ODS-4色谱柱,以含0.1%甲酸水溶液为流动相A,甲醇为流动相B,进行梯度洗脱,流速为0.25 mL•min-1,柱温35 ℃,进样量为2 μL;采用电喷雾离子源,负离子扫描,多反应监测模式,用于定量分析的帕米帕利离子对为m/z 297.3→m/z 253.1。结果 帕米帕利检测质量浓度的线性范围为100~10 000 ng•mL-1(r=0.995 4),定量下限为100 ng•mL-1;批内和批间准确度在92.0%~106.5%之间,批内和批间精密度均小于8.3%,基质效应、稳定性、选择性、残留均符合指导原则要求。临床患者帕米帕利体内随机血药浓度在330~1 693 ng•mL-1之间。结论 所建方法操作简便、快速,可用于帕米帕利的血药浓度测定。
关键词:  帕米帕利  液相色谱-质谱联用  血药浓度测定
DOI:10.13506/j.cnki.jpr.2024.05.005
基金项目:2022白求恩·求索-药学科研能力建设项目
出版日期:2024-05-25
Determination of Pamiparib in plasma of cancer patients by LC-MS / MS method
CHEN Shixian1,LIANG Xiaoxiao1,SHI Haiyan2,ZHANG Pei3,LIN Xiaoqing2,HUANG Xin1,2,3
(1.School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan 250355 ,China;2. Department of Pharmacy, the First Affiliated Hospital of Shandong First Medical University(Shandong Provincial Qianfoshan Hospital),Jinan 250014,China; 3.School of Pharmacy ,Shandong First Medical University ,Jinan 250000,China)
Abstract:
Objective To establish a liquid chromatography-mass spectrometry (LC-MS/MS) method for the determination of Pamidronate concentration in plasma of cancer patients.Methods Acetonitrile was used to precipitate plasma protein, and furosemide was used as the internal standard. The plasma concentration of Pamiparib was determined by LC-MS/MS. GL Sciences ODS-4 chromatographic column was used for gradient elution. The mobile phase A was 0.1% formic acid aqueous solution, and the mobile phase B was methanol. The flow rate was 0.25 mL•min-1, the column temperature was 35 ℃,and the injection volume was 2 μL. Negative ion scanning was performed using an electrospray ion source in a multi-reaction monitoring mode. The Pamiparib ion pair used for quantitative analysis was m/z 297.3→m/z 253.1. Results The linear range of Pamiparib was 100~10 000 ng•mL-1(r=0.995 4), and the lower limit of quantification was 100 ng•mL-1. The intra-batch and inter-batch accuracies were between 92.0% and 106.5%, and the intra-batch and inter-batch precisions were less than 8.3%. The matrix effect, stability, selectivity and residue all meet the requirements of the guiding principles. The random plasma concentration of Pamiparib in clinical patients was between 330-1 693 ng•mL-1. Conclusion The established method is simple and rapid, and can be used for the determination of plasma concentration of Pamiparib
Key words:  Pamiparib  LC-MS/MS  Determination of blood concentration
今日访问量:2339    总访问量:55338711
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司